15 Oct 2026Mankind Pharma Ltd board approves acquisition of 70% stake in Armed Cell Therapeutics B.V. for EUR 48Mn on 15 Oct 2026Restructuring
28 Sept 2026Mankind Pharma Ltd discloses resignation of statutory auditors S.R. Batliboi & Co. LLP from material subsidiary Bharat Serums and Vaccines Ltd on Sep 28, 2026KMP
17 Sept 2026Mankind Pharma Ltd voting results of Postal Ballot for appointment of Anish Vanraj Bafna as Independent Director on 17 Sep 2026Record Date
7 Sept 2026Mankind Pharma Ltd update on voluntary liquidation of subsidiary Bharat Serums and Vaccines Limited approved by members on 07 Sep 2026Insolvency
31 Aug 2026Mankind Pharma Ltd final update on sale of 100% stake in Broadway Hospitality Services Private Limited to AKRK Projects LLP on 31 Aug 2026Restructuring
31 Aug 2026Mankind Pharma Ltd cessation of Mr. Bharat Anand as Independent Director on 30 Aug 2026KMP
20 Aug 2026Mankind Pharma Ltd enters into exclusive in-licensing agreement with Chongqing Chenan Biopharmaceutical for Insulin Degludec products in India on 20 Aug 2026MOU
6 May 2026Mankind Pharma Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on May 06, 2026Audit Reports
16 Apr 2026Mankind Pharma Limited intimation regarding payment of interest and redemption of Non-Convertible Debentures under Regulation 57(1) with record date April 1, 2026Record Date
